Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

SUFENTANIL CITRATE INJECTION DIN 02483181

Status: Approved
Holder: HIKMA CANADA LIMITED
Molecule: SUFENTANIL (SUFENTANIL CITRATE)

Health Canada record

Active ingredient(s)SUFENTANIL (SUFENTANIL CITRATE) 50 MCG
Dosage formSolution
RouteIntravenous; Epidural
ScheduleNARCOTICS (CDSA I)
ClassHuman
ATCN01AH03 SUFENTANIL
Original market date
Current status date07-Jun-2022
SourceHealth Canada DPD

Establishment licence of the holder

Hikma Canada Limited — licence 3-002579, currently licensed, last inspection rating C (2022-04-26).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing SUFENTANIL (SUFENTANIL CITRATE)

DINProductCompanyFormStrengthStatus
02244147SUFENTANIL CITRATE INJECTION USPSANDOZ CANADA INCORPORATEDSolutionSUFENTANIL (SUFENTANIL CITRATE) 50 MCGMarketed
02442213SUFENTANIL CITRATE INJECTION USPSTERIMAX INCSolutionSUFENTANIL (SUFENTANIL CITRATE) 50 MCGMarketed
00619744SUFENTA INJ 50MCG/MLJANSSEN PHARMACEUTICA, DIVISION OF JANSSEN-ORTHO INC.LiquidSUFENTANIL (SUFENTANIL CITRATE) 50 MCGCancelled Post Market
01951319SUFENTA INJ 50MCG/MLJANSSEN INCLiquidSUFENTANIL (SUFENTANIL CITRATE) 50 MCGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
283402022-06-07Abbreviated New Drug Submission (ANDS)Administrative: Merger/Buy-out
258552021-05-03Abbreviated New Drug Submission (ANDS)CHANGE IN PRODUCT OWNERSHIP
215492018-11-26Abbreviated New Drug Submission (ANDS)
Request a quote for SUFENTANIL CITRATE INJECTION

How to read a Canadian DIN record